Fjord systems are susceptible to anthropogenic pressures, including discharges from wastewater treatment plants (WWTPs), which introduce micropollutants into coastal waters. We investigated the impact of micropollutants on bacteria and fungi within a fjord system adjacent to a significant petrochemical industry hub on the Swedish west coast. We characterised microbial assemblages along a land-to-sea transect, encompassing freshwater streams receiving agricultural and urban runoff, as well as the direct effluent from a WWTP. Our findings revealed elevated concentrations and a diverse array of micropollutants in the WWTP effluent and the stream running through the urban/industrial zone, highlighting these areas as major sources of pollution to the fjord. Bacterial and fungal communities inhabiting the WWTP effluent and the receiving marine waters near the marine outflow exhibited distinct structural compositions, indicating a selective pressure exerted in part by the micropollutant load. While freshwater sites generally displayed higher overall microbial diversity compared to marine sites, the WWTP effluent showed reduced diversity in both bacterial and fungal communities, likely due to the impact of micropollutants. Interestingly, marine sites far from the WWTP discharges exhibited a recovery in bacterial diversity, suggesting a potential response or adaptation. In contrast, fungal diversity remained comparable to that observed in other marine locations. Multivariate analyses identified physicochemical parameters and nutrients, alongside with summed fungicides and antibiotic stress as key factors driving the community dissimilarities across the fjord. Significant disruptions in potential bacterial metabolism and fungal ecological functions were evident at the WWTP discharge point, underscoring the ecological consequences of wastewater pollution.
Toward terminological clarity in digital biomarker research
Digital biomarker research has generated thousands of publications demonstrating associations between sensor-derived measures and clinical conditions, yet clinical adoption remains negligible. We identify a foundational




